A Prospective Study of Factors Related to Readmission and Mortality of COPD Patients in Hong Kong.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 800
- 试验地点
- 1
- 主要终点
- Mortality
研究概览
简要总结
Chronic obstructive pulmonary disease (COPD) is a common disease worldwide with a high burden on healthcare resources. The prevalence of COPD varied from 11.4 to 26.1% according to a recent multi-city population study using spirometry. In Hong Kong (HK), the prevalence rates of COPD in the elderly population aged ≥60 years were 25.9% and 12.4% based on the spirometric definition of forced expiratory volume in 1s (FEV1)/forced vital capacity (FVC) ratio <70% and the lower limit of normal of the FEV1/FVC respectively. In 2005, the crude mortality rate of COPD was 29.1/100 000, while the crude hospitalization rate was 193/100,000 in HK. In HK, COPD ranked second as a respiratory cause for hospitalization. In those 75 years or older, the hospitalization rate for COPD was as high as 2,225/100,000. The economic burden of COPD on the society is enormous.
Previous studies gave information on the overall morbidity, mortality and the prevalence of COPD in HK. One study compared the management of COPD patients in HK with other countries and found that COPD patients in HK were under-treated. No large scale study has looked into the details of COPD patients in HK, like their co-morbidities and how they are being treated and how these factors affect the readmission of these patients. Large prospective studies which incorporate all the potentially relevant variables are required to refine prediction of the important outcomes of AECOPD and thus to inform clinical decision making, for example on escalation of care, facilitated discharge and provision of palliative care.
详细描述
Aim of this study
The aim of this study is to assess the factors that are related to readmission and mortality of COPD patients in Hong Kong.
Method
This is a prospective observational study of patients. Patients who are admitted to the participating hospital with acute exacerbations of COPD (AECOPD) will be recruited. AECOPD was defined as occurring when a patient with background COPD11, with FEV1/FVC ratio <70%, presented with at least two major symptoms (increased dyspnea, increased sputum purulence, or increased sputum volume), or one major and one minor symptom (nasal discharge/congestion, wheeze, sore throat, or cough) for at least 2 consecutive days. Written informed consent will be obtained from each subject.
Inclusion criteria:
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects with a diagnosis of COPD according to the Global Initiative for chronic Obstructive Lung Disease (GOLD) Guideline16 with previous spirometry showing FEV1/FVC ratio of <0.70 with an AECOPD will be recruited for this study.
- •Age ≥40 years
排除标准
- •Subjects who have been diagnosed with asthma, bronchiectasis or other chronic lung disease apart from COPD will be excluded
- •Patients with history of lung resection
- •Those who are unable to give consent
结局指标
主要结局
Mortality
时间窗: 3 years
death
COPD exacerbations
时间窗: 3 years
Exacerbations that required treatment with antibiotic or systemic steroid
次要结局
未报告次要终点
研究者
Fanny W.S. Ko
Honorary Associate Professor
Chinese University of Hong Kong
